Silence Therapeutics (SLN) Enterprise Value: 2019-2025
Historic Enterprise Value for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to $122.8 million.
- Silence Therapeutics' Enterprise Value fell 84.04% to $122.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$419.3 million, marking a year-over-year decrease of 209.83%. This contributed to the annual value of $177.5 million for FY2024, which is 68.64% down from last year.
- Per Silence Therapeutics' latest filing, its Enterprise Value stood at $122.8 million for Q3 2025, which was up 40.62% from $87.3 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Enterprise Value high stood at $769.2 million for Q3 2024, and its period low was -$75.0 million during Q1 2025.
- Moreover, its 3-year median value for Enterprise Value was $177.5 million (2024), whereas its average is $329.9 million.
- Per our database at Business Quant, Silence Therapeutics' Enterprise Value surged by 5,453.13% in 2021 and then plummeted by 110.53% in 2025.
- Quarterly analysis of 5 years shows Silence Therapeutics' Enterprise Value stood at $615.8 million in 2021, then dropped by 21.55% to $483.1 million in 2022, then climbed by 17.15% to $565.9 million in 2023, then slumped by 68.64% to $177.5 million in 2024, then plummeted by 84.04% to $122.8 million in 2025.
- Its Enterprise Value stands at $122.8 million for Q3 2025, versus $87.3 million for Q2 2025 and -$75.0 million for Q1 2025.